Medicine of the future is biological. In order to turn the concept of biological implants and personalized therapies into tangible reality, scientists at Fraunhofer IGB are optimizing biological materials for processing with 3D printing techniques.
Like classical tissue engineering, the so-called bioprinting pursues the goal of producing biological or biologically functional tissue in the laboratory. The printed in vitro tissues will serve as test systems to answer questions about the efficacy of active substance candidates and thus help replace animal testing. In the future, as biological implants, they may also act to stimulate damaged tissue to regenerate, or substitute them.